NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.

Author(s): Devonshire AS, Whale AS, Gutteridge A, Jones G, Cowen S, Foy CA, Huggett JF

Publication: Anal Bioanal Chem, 2014, Vol. 406, Page 6499-512

PubMed ID: 24853859 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare circulating cell-free DNA (ccfDNA) yields obtained using four different extraction kits and to determine the effects of altering plasma and elution volumes. The effect of quantifying ccfDNA using droplet digital PCR (dPCR) rather than real-time quantitative PCR (qPCR) with SYBR green- or probe-based detection was also investigated.

Conclusion of Paper

Extraction with the QIAamp circulating nucleic acid (CNA) kit generated the highest ccfDNA yields, and resulted in much lower bias in fragment size than extraction with the QIAamp DNA blood mini kit. While cycle thresholds (CT) values for probe-based real-time qPCR were not affected by the ratio of plasma to elution volume, SYBR green CT values were significantly higher when the plasma to eluate ratio was 250 than when it was ≤125. CcfDNA yield increased linearly with increased plasma input up until 3 mL, after which yield plateaued. Quantification of ccfDNA levels by dPCR rather than by qPCR resulted in the same rank order of copies/mL of telomerase reverse transcriptase (TERT), ribonuclease P RNA component H1 (RPPH1) and endogenous retrovirus group 3 (ERV3), but the magnitude of the differences was greater with qPCR and a greater than 2-fold difference were observed for levels of seven reference genes. Reliability was improved when three reference genes were used to determine ccfDNA yield.

Studies

  1. Study Purpose

    The purpose of this study was to compare ccfDNA yields using four different extraction kits and to determine the effects of different PCR-based quantification methods, and plasma and elution volumes. Purchased plasma from 17 donors was stored at -80°C until use. Specimens were centrifuged at 5000 rpm, and specimens 1-5 and 6-17 were pooled. Plasma pools were aliquoted for storage at -80°C and fragmented ADH plasmid was added to half of the pools. DNA was extracted using the QIAamp CNA kit, NucleoSpin Plasma XS kit, FitAmp plasma/serum DNA isolation kit and the QIAamp DNA blood mini kit.

    Summary of Findings:

    Extraction with the QIAamp CNA kit generated ccfDNA yields that were 2.2-2.5 fold higher than when DNA was extracted using the QIAamp DNA blood mini kit, while <50% as much DNA was obtained using the NucleoSpin kit, and DNA yields using the FitAmp plasma/serum DNA isolation kit were at or below the limit of detection. Extraction with the QIAamp CNA kit allowed for >80% recovery of 115, 461 and 1448 bp fragments of ADH (albeit with slightly reduced recovery of the 115 bp fragment compared to the 461 bp fragment, 83% versus 99%, p<0.05), while recovery of ADH fragments following extraction with the DBM kit was highly size dependent with only 21% recovery of the 115 bp fragment and 37% recovery of the 461 bp fragment, and 58% recovery of the 1448 bp fragment(p<0.001 and p<0.05, respectively). The CT values for probe-based real-time PCR were not affected by the volume ratio of plasma to eluate, but SYBR green CT values were significantly higher when the volume ratio of plasma to elutant was 250 than when it was ≤125 using the CNA kit (p<0.0001). No effect was observed for the plasma volume to elution volume ratios examined by either real-time PCR assay when DNA was extracted with the NucleoSpin kit, but the kit did not allow an input per µL extract of>60. ccfDNA yield obtained with the CNA kit increased linearly with plasma input up until 3 mL, after which yield plateaued. Quantification of ccfDNA levels by dPCR rather than by qPCR resulted in the same rank order of copies/mL of tTERT, RPPH1 and ERV3, but the magnitude of the differences was greater with qPCR and a greater than 2-fold difference were observed for levels of seven reference genes. Reliability was improved when three reference genes were used to determine ccfDNA yield.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    DNA Real-time qPCR
    DNA Digital PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot size/volume 0.6 mL
    1.0 mL
    2.0 mL
    3.0 mL
    5.0 mL
    Analyte Extraction and Purification Rehydration of dried sample/specimen 5-20µL
    Real-time qPCR Specific Targeted nucleic acid ADH
    ALUJ
    TERT
    ERV3
    GAPDH
    NAGK
    RPH1
    VP
    Real-time qPCR Specific Detection method Probe-based
    Sybr-based
    Real-time qPCR Specific Length of gene fragment 115 bp
    461 bp
    1448 bp
    Analyte Extraction and Purification Analyte isolation method QIAamp CNA kit
    NucleoSpin Plasma XS kit
    FitAmp plasma/serum DNA isolation kit
    QIAamp DNA blood mini kit
    Real-time qPCR Specific Technology platform dPCR

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...